Nav: Home

Skin cancer teams up with Sonic the Hedgehog

March 08, 2016

Basal cell carcinoma (also known as basalioma or basal cell cancer -- BCC) is the most common, and the 5th expensive cancer type to cure, making about 90% of malignant skin tumors. Among risk factors there are genetic malfunctions, appearance of freckles, x-rays and radiation, burns or use of immunosuppressive medication (for organ transplantation, for instance).

'The work led by Sergey Nikolaev, University of Geneva, resulted in a finding that more than 80% of BCC cases contain gene mutations leading to tumor formation of other types, that were not associated with BCC initially. This discovery proves the existence of mechanisms helping BCC to resist anticancer therapy, which opens new range of opportunities for further clinical trials,' explains Vladimir Seplyarskiy, coauthor of the paper and junior researcher at the Bioengineering and Bioinformatics Department, Moscow State University.

Supersonic hedgehog & Co

Among genes and corresponding proteins where mutative malfunctions provoke cancer in 'the basal cell carcinoma inquiry' appear the elements of a Sonic hedgehog (Hh) signaling pathway. Hh manages task distribution among cells during the embryogenesis and further 'self-determination', as well as forming of organs' left-side and right-side orientation.

Under normal conditions the Sonic hedgehog signaling pathway is started by an eponymous signaling protein. Found first in drosophila, the Sonic hedgehog gene, which's absence made flies' embryos look like thorny balls, was actually named after Supersonic The Hedgehog, a character of comics and videogames.

85% of basalioma cover gene of the Sonic hedgehog signaling pathway, which leads to it's activation without a help of the 'regulating hedgehog'.

There belong PTCH1 receptors and SMO protein immersed in the cell membrane, which passes the hedgehogs protein's instruction to start protein synthesis to Gli transcription factor. Together with that, among 'the accused' in more than a half of tumor cells a 'broken' version of TP53 gene can be found, that under normal conditions suppresses forming of a tumor and orders the cells containing a defective DNA to 'commit suicide' by apoptosis.

Sabotaging treatment: who is behind that?

A SMO protein suppression, enabled by a medicine called Vismodegib, neutralizes breach's consequences in a chain interaction controlled by the Sonic hedgehog gene. Thanks to that medicine, the orders of the commander do not reach its subjects, and the job of the whole chain is stopped: so, pulling one of the first dominoes in a row, you can prevent falling of all other.

Though in 50% of cases the tumor tissue either does not react to medical treatment, or develop resistance. It is SMO protein mutations responsible for a half of those complications: they prevent interaction of Vismodegib and SMO, however reasons for the second half remain unknown.

That is why scientists payed attention to the fact that 85% of basal carcinoma contain genetic mutations, related to other cancer types development, including far more dangerous, such as melanoma.

After detecting those oncogenic gene mutations, scientists managed to confirm activation of corresponding cancer tracts experimentally. One of the important observations made during the research was that the detected mutations are often seen in a subtype of aggressive basaliomas.

'We researched the peculiarities of mutation process happening in basalis cellular carcinoma cells. More than 100 of cancer exomes (a part of genome consisting of protein-coding DNA sequences) allow both to find out, which genes provoke this type of cancer, and to research, which processes help storing mutations (most of which do not influence cancer development even in cancer samples). We compared mutation profile of basal cell carcinoma with other cancer type -- melanoma, also provoked by ultraviolet radiation. As the result we managed conclude that oxidative stress and UV play a more important role in basal cell carcinoma development,' tells Vladimir Seplyarskiy.

Criminogenic schemes

To catch the remaining accomplices red-handed in that nearly detective story, biologists analyzed 293 species of tumor tissues of 236 patients. 30 species belonged to Gorlin syndrome sufferers (a genetic disease, dramatically increasing the likelihood of multiple basaliomas appearance). Among them were also 23 Vismodegib-resistiant and 259 not exposed to the medicine.

Scientists compared mutations in basalioma, melanoma, Wilson disease (kidney cancer usually formed in the first-third year of life) and other cancer types, which are probably connected with Sonic hedgehog gene and its 'accomplices' of the same pathway.

The inquiry showed: of 387 genes in the 'list of suspects' several may contribute to the appearance of basalis cellular carcinoma and developing sustainability to treatment. Among them -- genes forming Hippo-YAP pathway, and not only Sonic hedgehog controlled pathways, that used to bear the whole responsibility. Also in basal carcinoma N-Myc protein content were exceeded, that was caused by point mutation (replacement of one nucleotide - a DNA 'letter') in ??1 site. In other tumor types, where N-Myc protein in a high concentration was 'caught red-handed' earlier, the reason was a mutation provoking multiple increase of MYCN gene's copies.

According to Vladimir Seplyarskiy, 'this study is a turning point in understanding molecular mechanisms of appearance and development of basalis carcinoma. The fact that basilioma cells are subject to oxidative stress may give start to an alternative anticancer therapy of basalis cellular carcinoma.'. The results also show which mutagens affect DNA damage in skin cells, the researcher says.
-end-


Lomonosov Moscow State University

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab